ClinicalTrials.gg
CompletedNCT07712224EAvs IV in LSGUpdated Jul 17, 2026

Comparison of Epidural and Intravenous Analgesia in Laparoscopic Sleeve Gastrectomy Patients

An observational study in Obesity, Bariatric Surgery and Laparoscopic Sleeve Gastrectomy, sponsored by Trabzon Kanuni Education and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Trabzon Kanuni Education and Research Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
106
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 353 studies in Obesity with a site in Turkey — 73 open to participants now, 90 under way, 16 of them phase 3. Obesity · Turkey.

Enrollment
57th of 160
106 · median 82
Started
2025
with 53 others
Observational
160 of 353
32 open now
Registered
308th of 353
by date

Among the 353 studies in Obesity with a site in Turkey, this one is the 57th largest by enrollment of the 160 observational ones that give a count, is one of 54 that started in 2025, is one of 160 observational ones, and was the 308th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

73 of the 353 studies in Obesity with a site in Turkey are open now. Recruiting first, the newest first:

68 more — sign in →

All 73 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 353 studies in Obesity with a site in Turkey, or all of them as a file.
02

Study summary

This retrospective observational study aimed to compare the effects of epidural analgesia and intravenous analgesia on early postoperative pulmonary function in patients undergoing laparoscopic sleeve gastrectomy. Preoperative and postoperative pulmonary function tests, pain scores, opioid consumption, and intraoperative respiratory parameters were evaluated.

Read the detailed description

This retrospective observational study was conducted at Trabzon Kanuni Training and Research Hospital. Adult patients who underwent laparoscopic sleeve gastrectomy between January 2025 and October 2025 were included. Patients were divided into two groups according to postoperative analgesia technique: epidural analgesia and intravenous analgesia.

The primary outcome was postoperative change in FEV1 at 24 hours after surgery. Secondary outcomes included changes in FVC and FEV1/FVC ratio, postoperative pain scores, additional opioid consumption, and intraoperative ventilatory parameters including peak airway pressure and plateau pressure.

Demographic data, perioperative variables, pulmonary function test results, arterial blood gas analyses, and analgesia-related data were retrospectively collected from hospital records. The study was approved by the Non-Interventional Scientific Research Ethics Committee of Trabzon University Faculty of Medicine.

03

Conditions studied

  • Obesity
  • Bariatric Surgery
  • Laparoscopic Sleeve Gastrectomy

Browse trials for

Keywords

  • Epidural Analgesia
  • Intravenous Analgesia
  • Pulmonary Function
  • FEV1
  • Postoperative Analgesia
  • Obesity
  • Bariatric Surgery
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult obese patients undergoing laparoscopic sleeve gastrectomy at a tertiary training and research hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged 18-65 years
  • III
  • Undergoing laparoscopic sleeve gastrectomy
  • Availability of preoperative and postoperative pulmonary function tests
  • Availability of arterial blood gas analysis data
  • Receipt of epidural or intravenous postoperative analgesia

Exclusion criteria

Exclusion Criteria:

  • Missing pulmonary function test data
  • Incomplete medical records
  • Conversion to open surgery
  • Severe respiratory disease affecting pulmonary function assessment
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
106 participants (actual)
Patient registry
No

Groups and cohorts

  • Epidural Analgesia

    Patients who received thoracic epidural analgesia for postoperative pain management after laparoscopic sleeve gastrectomy.

    Procedure: Epidural analgesia (0.125% bupivacaine/2mcg fentanyl solution)

  • Intravenous Analgesia

    Patients who received intravenous analgesia for postoperative pain management after laparoscopic sleeve gastrectomy.

    Drug: Intravenous analgesia

Interventions

  • ProcedureEpidural analgesia (0.125% bupivacaine/2mcg fentanyl solution)

    Thoracic epidural catheter-based analgesia using bupivacaine and fentanyl for postoperative pain management.

  • DrugIntravenous analgesia

    Intravenous tramadol-based patient-controlled analgesia for postoperative pain management.

06

What researchers measure

Primary outcomes

  1. Change in FEV1 at 24 Hours After Surgery

    Assessment of postoperative change in forced expiratory volume in 1 second (FEV1) measured before surgery and at postoperative 24 hours.

    Time frame: Preoperative period and postoperative 24 hours

07

Study locations

1 site
  • Trabzon Kanuni Training and Research Hospital
    Trabzon, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2025 to primary completion in Oct 2025, 9 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Jul 17, 2026
StartActual
Jan 1, 2025
Primary completionActual
Oct 15, 2025
CompletionActual
Oct 15, 2025
Last update
Jul 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07712224
Lead sponsor
Trabzon Kanuni Education and Research Hospital
Responsible party
Sponsor
First posted
Jul 17, 2026
Start date
Jan 1, 2025
Primary completion
Oct 15, 2025
Completion
Oct 15, 2025
Last update
Jul 17, 2026

Study contacts

esra kongur, M.D
principal investigator · Trabzon Kanuni Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion